pSivida
Follow
Follow Organisations, People and Lists
Stay on top of the latest updates for your desired data.
pSivida is a leading provider of miniaturised, sustained-release drug delivery products and is continuing the evolution of these systems.
Formerly an ASX-listed company, pSivida's intellectual property portfolio consists of over 150 issued patents in countries including the US, Europe, Japan, China and Australia.
pSivida, a NASDAQ-listed company, is developing products designed to revolutionise treatments, with a primary focus in ophthalmology.
Formerly an ASX-listed company, pSivida's intellectual property portfolio consists of over 150 issued patents in countries including the US, Europe, Japan, China and Australia.
pSivida, a NASDAQ-listed company, is developing products designed to revolutionise treatments, with a primary focus in ophthalmology.
